Risk assessment of drug interaction potential and concomitant dosing pattern on targeted toxicities in pediatric cancer patients.
about
Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic reviewAge-related toxicity in patients with rhabdomyosarcoma: a report from the children's oncology group.Pretreatment but not subsequent coincubation with midazolam reduces the cytotoxicity of temozolomide in neuroblastoma cellsUse of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens.Insights into the Roles of Midazolam in Cancer Therapy.
P2860
Risk assessment of drug interaction potential and concomitant dosing pattern on targeted toxicities in pediatric cancer patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Risk assessment of drug intera ...... in pediatric cancer patients.
@en
type
label
Risk assessment of drug intera ...... in pediatric cancer patients.
@en
prefLabel
Risk assessment of drug intera ...... in pediatric cancer patients.
@en
P2093
P2860
P1433
P1476
Risk assessment of drug intera ...... in pediatric cancer patients.
@en
P2093
Dimple Patel
Erin Dombrowsky
Gaurav Bajaj
Jeffrey M Skolnik
Jeffrey S Barrett
P2860
P2888
P304
P356
10.1208/S12248-013-9489-Z
P407
P577
2013-04-18T00:00:00Z
P5875
P6179
1019056079